Literature DB >> 9394764

What role does Helicobacter pylori play in dyspepsia and nonulcer dyspepsia? Arguments for and against H. pylori being associated with dyspeptic symptoms.

N J Talley1, R H Hunt.   

Abstract

A major role for Helicobacter pylori gastritis in nonulcer dyspepsia (NUD) is controversial. Gastroduodenal dysfunction may be associated with H. pylori infection, but there is little evidence for a causal link with dyspepsia. Population-based studies with appropriate methodology have generally failed to confirm an association between H. pylori and NUD. Furthermore, no definite association between subgroups of NUD (ulcer-like, dysmotility-like, reflux-like, and nonspecific) and H. pylori has been identified however the subgroups have been defined, and no specific symptom pattern characterizes patients with H. pylori infection. Whether H. pylori-induced alterations of gastric physiology can explain NUD remains open to debate while we await the results of more specific experiments. Although acid secretion in response to gastrin-releasing peptide may be increased in a subset of NUD patients who are infected with H. pylori, uninfected patients with NUD have not been assessed and the results require confirmation. Most studies suggest no association between H. pylori and gastroduodenal motor or sensory dysfunction in NUD. Treatment trials have been unconvincing. The trials with bismuth therapy have not been adequately blinded. Furthermore, some studies suggest that H. pylori-negative patients with NUD may respond to bismuth treatment, although the results have not been uniform. Therapies aimed at curing H. pylori infection have produced mixed results, with small positive and negative trials. The trials that have used adequate outcome measures have more often than not been negative. Based on current evidence, H. pylori is not established to be of causal importance in NUD.

Entities:  

Mesh:

Year:  1997        PMID: 9394764     DOI: 10.1016/s0016-5085(97)80016-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  24 in total

1.  Contributors to antibiotic resistance. Antibiotics should not be first treatment for acne.

Authors:  M J Cheesbrough
Journal:  BMJ       Date:  1999-03-06

2.  Treating non-ulcer dyspepsia and H pylori.

Authors:  S J van Zanten
Journal:  BMJ       Date:  2000-09-16

Review 3.  Helicobacter pylori eradication in patients with non-ulcer dyspepsia.

Authors:  H H Xia; N J Talley
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

4.  Predictive role of H. pylori infection in functional dyspepsia.

Authors:  Hagan Buyukhatipoglu; Yavuz Pehlivan; Ramazan Geyik; Abdurrahman Kadayifci
Journal:  J Natl Med Assoc       Date:  2007-07       Impact factor: 1.798

5.  Management of Helicobacter pylori infection. Eradication treatment should be limited to patients with proved peptic ulceration.

Authors:  R Foy; J Parry; C Woodman
Journal:  BMJ       Date:  1998-04-18

6.  An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.

Authors:  S J Veldhuyzen van Zanten; N Flook; N Chiba; D Armstrong; A Barkun; M Bradette; A Thomson; F Bursey; P Blackshaw; D Frail; P Sinclair
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

7.  Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group.

Authors:  N J Talley; J Janssens; K Lauritsen; I Rácz; E Bolling-Sternevald
Journal:  BMJ       Date:  1999-03-27

Review 8.  Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group.

Authors:  P Moayyedi; S Soo; J Deeks; D Forman; J Mason; M Innes; B Delaney
Journal:  BMJ       Date:  2000-09-16

Review 9.  Management of functional dyspepsia: Unsolved problems and new perspectives.

Authors:  Ahmed Madisch; Stephan Miehlke; Joachim Labenz
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

Review 10.  Helicobacter pylori: present status and future prospects in Japan.

Authors:  Hidekazu Suzuki; Toshifumi Hibi; Barry James Marshall
Journal:  J Gastroenterol       Date:  2007-02-16       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.